A detailed history of Jenkins Wealth transactions in Nrx Pharmaceuticals, Inc. stock. As of the latest transaction made, Jenkins Wealth holds 14,176 shares of NRXP stock, worth $18,287. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,176
Holding current value
$18,287
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 11, 2023

BUY
$0.79 - $9.19 $11,199 - $130,277
14,176 New
14,176 $0

Others Institutions Holding NRXP

# of Institutions
2
Shares Held
17.4K
Call Options Held
0
Put Options Held
0

About NRX Pharmaceuticals, Inc.


  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $87.3M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Jenkins Wealth Portfolio

Follow Jenkins Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jenkins Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Jenkins Wealth with notifications on news.